Here are the Form 4 insider transactions from Translational Development Acquisition Corp. (TDAC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TDAC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TDAC filings page.
Translational Development Acquisition Corp. director and CEO Michael B. Hoffman bought 53,395 warrants in an open-market transaction. The warrants were purchased at a weighted average price of about $0.79 per warrant, for aggregate proceeds of $42,280.50. Each warrant entitles the holder to acquire one Class A ordinary share at an exercise price of $11.50 per share. The warrants become exercisable 30 days after completion of the company’s initial business combination and expire five years after that business combination, or earlier upon redemption or liquidation. Following this transaction, Hoffman directly holds 53,395 warrants.